177 related articles for article (PubMed ID: 37150157)
1. Melatonin and Ramelteon for the treatment of delirium: A systematic review and meta-analysis.
Beaucage-Charron J; Rinfret J; Coveney R; Williamson D
J Psychosom Res; 2023 Jul; 170():111345. PubMed ID: 37150157
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Melatonin and melatonin agonist for delirium in the elderly patients.
Chakraborti D; Tampi DJ; Tampi RR
Am J Alzheimers Dis Other Demen; 2015 Mar; 30(2):119-29. PubMed ID: 24946785
[TBL] [Abstract][Full Text] [Related]
4. Melatonergic agents in the prevention of delirium: A network meta-analysis of randomized controlled trials.
Yang CP; Tseng PT; Pei-Chen Chang J; Su H; Satyanarayanan SK; Su KP
Sleep Med Rev; 2020 Apr; 50():101235. PubMed ID: 31801100
[TBL] [Abstract][Full Text] [Related]
5. Melatonin for delirium prevention in hospitalized patients: A systematic review and meta-analysis.
Khaing K; Nair BR
J Psychiatr Res; 2021 Jan; 133():181-190. PubMed ID: 33348252
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Use of Ramelteon for Delirium in Hospitalized Patients: A Systematic Review and Meta-Analyses.
Dang V; Mansukhani MP; Wang Z; Kinzelman Vesely E; Kolla BP
J Acad Consult Liaison Psychiatry; 2023; 64(1):65-72. PubMed ID: 35718086
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Delirium in Critically Ill Patients Prescribed Melatonin or Ramelteon.
Romero N; Dube KM; Lupi KE; DeGrado JR
Ann Pharmacother; 2021 Nov; 55(11):1347-1354. PubMed ID: 33715466
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
9. Melatonin for the prevention of postoperative delirium in older adults: a systematic review and meta-analysis.
Campbell AM; Axon DR; Martin JR; Slack MK; Mollon L; Lee JK
BMC Geriatr; 2019 Oct; 19(1):272. PubMed ID: 31619178
[TBL] [Abstract][Full Text] [Related]
10. Role of Ramelteon in Reduction of As-Needed Antipsychotics in Elderly Patients with Delirium in a General Hospital Setting.
Pinkhasov A; James SA; Fazzari M; Singh D; Lam S
Clin Drug Investig; 2017 Dec; 37(12):1137-1141. PubMed ID: 28933013
[TBL] [Abstract][Full Text] [Related]
11. Melatonin and its analogues for the prevention of postoperative delirium: A systematic review and meta-analysis.
Han Y; Wu J; Qin Z; Fu W; Zhao B; Li X; Wang W; Sha T; Sun M; Li J; Zeng Z; Chen Z
J Pineal Res; 2020 May; 68(4):e12644. PubMed ID: 32145098
[TBL] [Abstract][Full Text] [Related]
12. Melatonin and the Prevention and Management of Delirium: A Scoping Study.
Choy SW; Yeoh AC; Lee ZZ; Srikanth V; Moran C
Front Med (Lausanne); 2017; 4():242. PubMed ID: 29376051
[TBL] [Abstract][Full Text] [Related]
13. Association of Delirium Response and Safety of Pharmacological Interventions for the Management and Prevention of Delirium: A Network Meta-analysis.
Wu YC; Tseng PT; Tu YK; Hsu CY; Liang CS; Yeh TC; Chen TY; Chu CS; Matsuoka YJ; Stubbs B; Carvalho AF; Wada S; Lin PY; Chen YW; Su KP
JAMA Psychiatry; 2019 May; 76(5):526-535. PubMed ID: 30810723
[TBL] [Abstract][Full Text] [Related]
14. Melatonin Receptor Agonists for the Prevention of Delirium: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Maneeton B; Kongsaengdao S; Maneeton N; Likhitsathian S; Woottiluk P; Kawilapat S; Srisurapanont M
Curr Neuropharmacol; 2022; 20(10):1956-1968. PubMed ID: 35524672
[TBL] [Abstract][Full Text] [Related]
15. Effect of Administration of Ramelteon, a Melatonin Receptor Agonist, on the Duration of Stay in the ICU: A Single-Center Randomized Placebo-Controlled Trial.
Nishikimi M; Numaguchi A; Takahashi K; Miyagawa Y; Matsui K; Higashi M; Makishi G; Matsui S; Matsuda N
Crit Care Med; 2018 Jul; 46(7):1099-1105. PubMed ID: 29595562
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapies for sleep disturbances in dementia.
McCleery J; Sharpley AL
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009178. PubMed ID: 33189083
[TBL] [Abstract][Full Text] [Related]
17. [Delirium, insomnia in hospitalization and ramelteon].
Ito T
Nihon Rinsho; 2012 May; 70(5):907-13. PubMed ID: 22620020
[TBL] [Abstract][Full Text] [Related]
18. Emerging Role of Melatonin and Melatonin Receptor Agonists in Sleep and Delirium in Intensive Care Unit Patients.
Mo Y; Scheer CE; Abdallah GT
J Intensive Care Med; 2016 Aug; 31(7):451-5. PubMed ID: 26092575
[TBL] [Abstract][Full Text] [Related]
19. The role of melatonin and melatonin receptor agonist in the prevention of sleep disturbances and delirium in intensive care unit - a clinical review.
Lewandowska K; Małkiewicz MA; Siemiński M; Cubała WJ; Winklewski PJ; Mędrzycka-Dąbrowska WA
Sleep Med; 2020 May; 69():127-134. PubMed ID: 32074506
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotics for treatment of delirium in hospitalised non-ICU patients.
Burry L; Mehta S; Perreault MM; Luxenberg JS; Siddiqi N; Hutton B; Fergusson DA; Bell C; Rose L
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD005594. PubMed ID: 29920656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
